What one share of Indivior Pharmaceuticals holds
Indivior Pharmaceuticals, Inc. and its subsidiaries (together, "Indivior" or the "Company") is the market leader in long-acting injectable medications for opioid use disorder (OUD). Indivior is focused on delivering evidence-based pharmacotherapies for OUD and is committed to advancing the neurobiological understanding of OUD as a chronic, relapsing, but treatable brain disease.
Indivior Pharmaceuticals’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-06-30; the balance sheet is as of 2026-06-30.
| Sales | $10.32 |
|---|---|
| Profit | $2.76 |
| Capex (buildings and equipment) | $0.55 |
| Free cash flow | −$0.86 |
| Cash and investments | $1.88 |
| Debt | $4.13 |
| Book value | −$1.76 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2021 | $5.21 | $1.35 | $0.03 | $2.30 | — | $0.83 |
| 2022 | $6.48 | −$0.32 | $0.04 | −$0.06 | — | −$0.11 |
| 2023 | $7.98 | −$0.92 | $0.06 | −$2.25 | — | −$1.34 |
| 2024 | $8.93 | $0.05 | $0.22 | $0.05 | — | −$2.70 |
| 2025 | $9.68 | $1.64 | $0.52 | −$0.73 | — | −$0.78 |
Common questions about Indivior Pharmaceuticals
How much does one share of Indivior Pharmaceuticals earn?
Over the last 12 months, each share of Indivior Pharmaceuticals earned $2.76 of profit on $10.32 of sales, keeping about 27¢ of every $1 (profit margin).
Does Indivior Pharmaceuticals pay a dividend?
Indivior Pharmaceuticals didn’t pay a dividend over the last 12 months, according to its SEC filings.
What is Indivior Pharmaceuticals’s book value per share?
Indivior Pharmaceuticals’s book value is negative (−$1.76 per share): it owes more than everything it owns is recorded at, often after years of buying back its own shares, as of June 30, 2026.
How much cash and debt does each share of Indivior Pharmaceuticals have?
Each share of Indivior Pharmaceuticals has $1.88 of cash and investments and $4.13 of debt, as of June 30, 2026.
What is Indivior Pharmaceuticals’s free cash flow per share?
−$0.86 per share over the last 12 months. Free cash flow is the cash left over after spending on buildings and equipment.
How has Indivior Pharmaceuticals’s profit per share changed over time?
Profit per share went from $1.35 in 2021 to $1.64 in 2025, growing about 5.0% a year (adjusted for stock splits).
Has Indivior Pharmaceuticals bought back shares?
Indivior Pharmaceuticals’s share count fell about 16% from 2021 to 2025. Through buybacks, each remaining share owns a bigger slice of the company.
From its SEC filings. For education only, not investment advice. New to these words? See the StockSlicer glossary.